The government is likely to take a less harsh stand on foreign direct investment (FDI) in pharmaceutical companies to ensure a balance between public health concerns and the need to attract investments.
An inter-ministerial group set up by the finance ministry has favoured that all brownfield FDI in pharmaceuticals up to 49% stake should be allowed under the automatic route, two officials familiar with the development told ET. The foreign investment promotion board (FIPB) may block only those FDI proposals which may result in transfer of management control to the foreign buyer.
No comments:
Post a Comment